Physician profile
Rae Lynne Hornsby
NPI 1518917061
$4,105.29
in general payments reported to CMS, 2019-2025
16 companies · $415 in 2025
The $415 reported for 2025 was more than what 82% of Developmental - Behavioral Pediatrics providers received nationally (typical 2025 total: $79.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $151 · 2021: $399 · 2022: $744 · 2023: $1,070 · 2024: $926 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,412.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $1,151.57 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $935.74 | 2021-2025 | Qelbree, Qelbree |
| Tris Pharma INC | $631.41 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $607.73 | 2021-2025 | Azstarys |
| Neos Therapeutics, Lp | $199.97 | 2019-2024 | Adzenys Xr-Odt |
| Takeda Pharmaceuticals U.S.A., INC. | $181.39 | 2019-2022 | |
| Adlon Therapeutics L.P. | $75.53 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $70.03 | 2025 | Jornay Pm |
| Noven Therapeutics, LLC | $66.69 | 2024 | Xelstrym, Secuado |
| Idorsia Pharmaceuticals US INC | $66.24 | 2023-2024 | Quviviq |
| Rhodes Pharmaceuticals L.P. | $36.81 | 2019 | |
| Shire North American Group INC | $24.08 | 2019 | |
| Aytu Biopharma, INC. | $16.84 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.74 | 2025 | Caplyta |
| Arbor Pharmaceuticals, INC. | $12.85 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Hornsby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.